This was confirmed by STAT3 transcriptional activation ELISA, in which wild-type Tsc2(+/+) MEFs and TSC2(+) AML cells were treated with their corresponding TSC2-deficient cell conditioned media for 1 h, which strongly promoted STAT3 nuclear activation (Fig. 2c). The gene discussed is TSC2; the disease is acute myeloid leukemia.